STOCK TITAN

embecta to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Embecta Corp. (Nasdaq: EMBC) announced it will host a conference call on December 20, 2022, at 8:00 a.m. ET to discuss its fiscal Q4 and full-year 2022 financial results, along with preliminary guidance for fiscal year 2023. As a leading diabetes care company, Embecta aims to leverage its nearly 100-year expertise in insulin delivery to enhance life quality for diabetes patients. The call will discuss significant operational updates, and a replay will be available post-call on their investor relations website.

Positive
  • Embecta is one of the largest pure-play diabetes care companies globally.
  • The company has nearly 100 years of experience in insulin delivery.
Negative
  • None.

PARSIPPANY, N.J., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host a conference call to discuss its fiscal fourth quarter and full year 2022 financial results, and provide an operational update, including preliminary fiscal year 2023 financial guidance, at 8:00 a.m. Eastern Time (ET) on Tuesday, December 20, 2022.

Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.

A webcast replay of the call will be available beginning at 11:00 a.m. ET on December 20, 2022, via the embecta investor relations website and archived on the website for one year.

About embecta 
embecta, formerly part of BD (Becton, Dickinson and Company), is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com.

CONTACTS 
 
Investors:
Pravesh Khandelwal
VP, Head of Investor Relations
551-264-6547
Contact IR

Media:
Christian Glazar
Sr. Director, Corporate Communications 
908-821-6922 
Contact Media Relations


FAQ

What is the date and time of Embecta's conference call for Q4 2022 results?

Embecta's conference call is scheduled for December 20, 2022, at 8:00 a.m. ET.

How can I access the Embecta conference call?

You can access the live webcast of the Embecta conference call through their investor relations website.

Will there be a replay of Embecta's conference call?

Yes, a replay will be available beginning at 11:00 a.m. ET on December 20, 2022.

What will Embecta discuss during the conference call?

The call will cover fiscal Q4 and full-year 2022 financial results and preliminary guidance for fiscal year 2023.

What is Embecta's ticker symbol on Nasdaq?

Embecta's ticker symbol is EMBC.

Embecta Corp.

NASDAQ:EMBC

EMBC Rankings

EMBC Latest News

EMBC Stock Data

844.18M
57.70M
0.47%
99.81%
3.17%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
WILMINGTON